All News

A conversation with Antonia Biggs, PhD, professor and acting director of the Advancing New Standards in Reproductive Health Program at the University of California, San Francisco.

Joseph DiPiro, PharmD, FCCP, FAAAS, editor of the American Society of Health-System Pharmacists 2025 Pharmacy Forecast, discussed key themes in the forecast that will impact health-system pharmacy in 2025.

A poll conducted by the Global Healthy Living Foundation found 11% of respondents with chronic conditions do not plan to get vaccinated for flu, COVID-19 or RSV.

Researchers wanted to better understand the accuracy of advertising practices behind websites selling compounded GLP-1 RAs.

Support for and personal interest in expanded access to advance provision and over-the-counter medication abortion has increased significantly since the constitutional right to abortion was overturned by the Supreme Court.

Known as “The Nutrition Pharmacist,” Sarah Gray, PharmD, GAICD, recently joined Drug Topics to discuss her dual profession within health care.

A conversation with Jennifer Bacci, PharmD, MPH, endowed associate professor of Innovative Pharmacy Practice at the University of Washington School of Pharmacy.

Researchers compared the safety and reactogenicity of simultaneous doses of recombinant zoster vaccine paired with 2 separate types of inactivated influenza vaccines.

The therapy is the first and only prefilled testosterone cypionate injection approved by the FDA.

Sarah Gray, PharmD, GAICD, explored the unique combination of being both a pharmacist and nutritionist.

A conversation with David Nau, PhD, professor of social and administrative pharmacy, and director of assessment at Ohio Northern University.

RGT-075 from Regor Therapeutics demonstrated a statistically significant 5% placebo-adjusted weight loss in adult patients with obesity or overweight.

The Federal Trade Commission released its second interim staff report on industry-leading pharmacy benefit managers and their practices specifically regarding specialty drugs.

Ahead of its first general meeting in 2025, lawmakers called on the FTC to vote “yes” on releasing a second interim staff report on PBMs.

A conversation with Heather Folz, PharmD, BCACP and Christina H. Sherrill, PharmD, BCACP, BC-ADM.

A combination of ibuprofen and acetaminophen was found to be superior to hydrocodone and acetaminophen in managing pain after impacted mandibular third-molar extraction surgery.

Rite Aid recently released a survey detailing US patients’ perspective of how they engage with their pharmacists.

Sarah Gray, PharmD, GAICD, discussed her experience as a pharmacist who added nutrition counseling to her clinical expertise.

Jennifer Clements, PharmD, BCACP, BC-ADM, BCPS, CDCES, FADCES, FCCP, discussed current GLP-1 medication offerings and how each impacts patients differently.

To celebrate National Pharmacists Day on January 12, Drug Topics gathered its pharmacist interviews from the past year, exploring expert industry insights in a variety of topics.

Heather Folz, PharmD, BCACP and Christina H. Sherrill, PharmD, BCACP, BC-ADM, discuss a recent study that examined how wearing a continuous glucose monitor impacts student pharmacists.

Sarah Gray, PharmD, GAICD, known as the Nutrition Pharmacist, joined Drug Topics to discuss her experience with patients looking to begin healthier lifestyles at the start of a new year.

Researchers performed a systematic literature review of the efficacy of amitriptyline for treating patients with irritable bowel syndrome.

Investigators of a recent study said targeted interventions are needed to reduce the global burden, particularly in developing countries.

Researchers conducted a literature research review to further understand the current evidence regarding diagnosis and treatment for peptic ulcer disease.

Henry Ukachukwu Michael, PhD, discusses the importance of optimizing medication utilization in patients with long COVID.

These recommendations were voted on at the October 2024 Advisory Committee on Immunization Practices meeting.

MET-097i from Metsera demonstrated substantial reductions in mean body weight in patients with obesity or overweight who did not have type 2 diabetes.